X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (546) 546
Publication (52) 52
Book Chapter (13) 13
Conference Proceeding (10) 10
Book / eBook (3) 3
Book Review (2) 2
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (336) 336
male (222) 222
female (212) 212
gastroenterology & hepatology (206) 206
middle aged (193) 193
adult (177) 177
index medicus (125) 125
aged (104) 104
antiviral agents - therapeutic use (74) 74
gastroenterology and hepatology (69) 69
treatment outcome (68) 68
cirrhosis (46) 46
infection (46) 46
therapy (46) 46
drug therapy, combination (45) 45
hepatitis c, chronic - drug therapy (45) 45
interferon (43) 43
follow-up studies (42) 42
hepatitis (42) 42
prevalence (40) 40
interferon-alpha - therapeutic use (39) 39
hepatitis c virus (38) 38
hepacivirus - genetics (37) 37
prospective studies (37) 37
liver cirrhosis (36) 36
genotype (35) 35
hepatitis c (35) 35
retrospective studies (34) 34
adolescent (33) 33
ribavirin - therapeutic use (33) 33
antiviral agents - adverse effects (32) 32
surgery (32) 32
time factors (32) 32
health aspects (31) 31
hepatitis b (30) 30
liver transplantation (30) 30
ribavirin (30) 30
gastroenterology (28) 28
hepatitis b virus (28) 28
hepatitis b virus - genetics (28) 28
liver (28) 28
biopsy (27) 27
recombinant proteins (27) 27
virology (27) 27
medicine & public health (26) 26
risk factors (26) 26
chronic disease (25) 25
management (25) 25
aged, 80 and over (24) 24
animals (24) 24
hepatitis b, chronic - drug therapy (24) 24
italy (24) 24
lamivudine (24) 24
medicine, general & internal (24) 24
rna, viral - blood (24) 24
virus-infection (24) 24
polyethylene glycols - therapeutic use (23) 23
recurrence (23) 23
transplantation (23) 23
antiviral agents - administration & dosage (22) 22
hepatitis c, chronic - virology (22) 22
liver - pathology (22) 22
prognosis (22) 22
viral load (22) 22
hepatitis delta virus - genetics (21) 21
hepatocellular-carcinoma (21) 21
antibodies (20) 20
disease (20) 20
hepatitis c, chronic - complications (20) 20
hepatology (20) 20
pharmacology & pharmacy (20) 20
epidemiology (19) 19
hepatitis b surface antigens - analysis (19) 19
lamivudine - therapeutic use (19) 19
liver cirrhosis - complications (19) 19
viruses (19) 19
analysis (18) 18
antiviral agents (18) 18
diagnosis (18) 18
hepatitis b - immunology (18) 18
multivariate analysis (18) 18
antigens (17) 17
care and treatment (17) 17
case-control studies (17) 17
chronic hepatitis c (17) 17
cohort studies (17) 17
efficacy (17) 17
hcv (17) 17
helicobacter pylori (17) 17
hepacivirus - drug effects (17) 17
infectious diseases (17) 17
interferon-alpha - administration & dosage (17) 17
italy - epidemiology (17) 17
ribavirin - adverse effects (17) 17
antigen (16) 16
hdv (16) 16
hepatitis b surface antigen (16) 16
hepatitis delta virus - immunology (16) 16
infections (16) 16
liver cirrhosis - pathology (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 607 - 615
Journal Article
Cold Spring Harbor Perspectives in Medicine, ISSN 2157-1422, 07/2015, Volume 5, Issue 7, pp. 1 - 10
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1889 - 1898
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 685 - 697
Journal Article
Seminars in Liver Disease, ISSN 0272-8087, 08/2012, Volume 32, Issue 3, pp. 193 - 194
Journal Article
Hepatology, ISSN 0270-9139, 04/2015, Volume 61, Issue 4, pp. 1109 - 1111
Journal Article
Recenti Progressi in Medicina, ISSN 0034-1193, 07/2016, Volume 107, Issue 7, pp. 355 - 359
Journal Article
Hepatology, ISSN 0270-9139, 04/2015, Volume 61, Issue 4, pp. 1109 - 1111
Journal Article
Journal Article
Recenti progressi in medicina, 07/2016, Volume 107, Issue 7, p. 355
Infection with the hepatitis B virus (HBV) has much diminished in Italy in the last 25 years; at present, all Italian nationals aged under 36 years are... 
Hepatitis B, Chronic | Humans | Italy | Hepatitis B virus | Hepatitis B Surface Antigens
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
In patients with HCV infection and no previous treatment, the addition of telaprevir to peginterferon–ribavirin resulted in higher response rates than those... 
GENETIC-VARIATION | IL28B | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | GENOTYPE-1 PATIENTS | PEGINTERFERON ALPHA-2B | AMERICAN PATIENTS | ALPHA-2B PLUS RIBAVIRIN | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals
Journal Article